ORIGINAL PAPER
The impact of donor-recipient sex matching on transplant-related complications in children after allogeneic haematopoietic stem cell transplantation – a single-centre, retrospective study
1
Student Scientific Association at the Chair and Department of Paediatric Oncology, Haematology, and Transplantology, Medical University of Lublin, Poland
2
Department of Paediatric Oncology, Haematology, and Transplantology, Medical University of Lublin, Poland
Submission date: 2019-03-13
Final revision date: 2019-05-20
Acceptance date: 2019-05-20
Publication date: 2019-06-28
Pediatr Pol 2019;94(3):158-161
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Allogeneic haematopoietic stem cell transplantation (HSCT) is a well-established therapeutic option used in the treatment of malignant and non-malignant disorders. According to numerous studies, there is a correlation between donor sex or sex mismatching between donor and recipient and increased risk of graft-versus-host diseases.
Aim of the study:
The aim of this study was to assess the impact of donor-recipient sex mismatching on the incidence of transplant-related complications in children undergoing allogeneic HSCT.
Material and methods:
We conducted a retrospective study comparing the prevalence of transplant-related adverse events between female donor – female recipient, female donor – male recipient, male donor – male recipient, and male donor – female recipient groups. The study population included 198 patients from the department’s database, who underwent allogeneic HSCT between 2001 and 2018 in the Department of Paediatric Haematology, Oncology, and Transplantology in Lublin.
Results:
No statistically significant differences in prevalence of transplant-related complications between the four groups were found in this study: acute graft-versus-host disease (p = 0.53), chronic graft-versus-host disease (p = 0.69), hepatic veno-occlusive disease (p = 0.41), renal failure (p = 0.81), bleeding (p = 0.51), cytomegaly virus infection (p = 0.41), Epstein-Barr infection (p = 0.29), and fungal infection (p = 0.31).
Conclusions:
The study showed no correlation between sex mismatching and HSCT complication frequency in children. The results of this study suggest that the donor’s gender might not be a crucial factor in screening for potential donors in the paediatric population. Rising evidence of the lack of a direct impact of a donor’s gender on overall HSCT transplant outcomes and adverse events in the paediatric population might in future change the criteria we follow when looking for potential donors. In conclusion, there is a need for prospective observational studies, which could investigate the mechanisms of adverse events and multicentre retrospective studies, which would allow larger homogeneous populations to be gathered to further research the impact of donor’s demographics on allogeneic HSCT outcomes and complications.
Allogeneic haematopoietic stem cell transplantation (HSCT) is a well-established therapeutic option used in the treatment of malignant and non-malignant disorders. According to numerous studies, there is a correlation between donor sex or sex mismatching between donor and recipient and increased risk of graft-versus-host diseases.
Aim of the study:
The aim of this study was to assess the impact of donor-recipient sex mismatching on the incidence of transplant-related complications in children undergoing allogeneic HSCT.
Material and methods:
We conducted a retrospective study comparing the prevalence of transplant-related adverse events between female donor – female recipient, female donor – male recipient, male donor – male recipient, and male donor – female recipient groups. The study population included 198 patients from the department’s database, who underwent allogeneic HSCT between 2001 and 2018 in the Department of Paediatric Haematology, Oncology, and Transplantology in Lublin.
Results:
No statistically significant differences in prevalence of transplant-related complications between the four groups were found in this study: acute graft-versus-host disease (p = 0.53), chronic graft-versus-host disease (p = 0.69), hepatic veno-occlusive disease (p = 0.41), renal failure (p = 0.81), bleeding (p = 0.51), cytomegaly virus infection (p = 0.41), Epstein-Barr infection (p = 0.29), and fungal infection (p = 0.31).
Conclusions:
The study showed no correlation between sex mismatching and HSCT complication frequency in children. The results of this study suggest that the donor’s gender might not be a crucial factor in screening for potential donors in the paediatric population. Rising evidence of the lack of a direct impact of a donor’s gender on overall HSCT transplant outcomes and adverse events in the paediatric population might in future change the criteria we follow when looking for potential donors. In conclusion, there is a need for prospective observational studies, which could investigate the mechanisms of adverse events and multicentre retrospective studies, which would allow larger homogeneous populations to be gathered to further research the impact of donor’s demographics on allogeneic HSCT outcomes and complications.
REFERENCES (15)
1.
Styczyński J, Balwierz W, Dembowska-Bagińska B, et al. Paediatric oncology and haematology in Poland: position paper. Pediatr Pol 2018; 93: 451-461.
2.
Nannya Y, Kataoka K, Hangaishi A, et al. The negative impact of female donor/male recipient combination in allogeneic hematopoietic stem cell transplantation depends on disease risk. Transpl Int 2011; 24: 469-476.
3.
Randolph SS, Gooley TA, Warren EH, et al. Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood 2004; 103: 347-352.
4.
Goulmy E, Schipper R, Pool J, et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 1996; 334: 281-285.
5.
Markiewicz M, Siekiera U, Dzierzak-Mietla M, et al. The impact of H-Y mismatches on results of HLA-matched unrelated allogeneic hematopoietic stem cell transplantation. Transplant Proc 2010; 42: 3297-3300.
6.
Przepiorka D, Smith TL, Folloder J, et al. Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 1999; 94: 1465-1470.
7.
Friedrich P, Guerra-Garcia P, Stetson A, et al. Young Female Donors Do Not Increase the Risk of Graft-versus-Host Disease or Impact Overall Outcomes in Pediatric HLA-Matched Sibling Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2018; 24: 96-102.
8.
Verdijk RM, Kloosterman A, Pool J, et al. Pregnancy induces minor histocompatibility antigen–specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy. Blood 2004; 103: 1961-1964.
9.
Linscheid C, Petroff MG. Minor histocompatibility antigens and the maternal immune response to the fetus during pregnancy. Am J Reprod Immunol 2013; 69: 304-314.
10.
van Kampen CA, Versteeg-van der Voort MF, Langerak-Langerak J, et al. Pregnancy can induce long-persisting primed CTLs specific for inherited paternal HLA antigens. Hum Immunol 2001; 62: 201-207.
11.
Remberger M, Kumlien G, Aschan J, et al. Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2002; 8: 674-682.
12.
Bross DS, Tutschka PJ, Farmer ER, et al. Predictive factors for acute graft-versus-host disease in patients transplanted with HLA-identical bone marrow. Blood 1984; 63: 1265-1270.
13.
Randolph SSB, Gooley TA, Warren EH, et al. Female donors contribute to a selective graft-versusleukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood 2004; 103: 347-352.
14.
Anasetti C, Logan BR, Lee SJ, et al. Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors. N Eng J Med 2012; 367: 1487-1496.
15.
Gahrton G, Iacobelli S, Apperley J, et al. The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants. Bone Marrow Transplant 2005; 35: 609-617.
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
